Plenary Lecture:

Greg Verdine, PhD

Co-Founder, President, and CEO at LifeMine Therapeutics

Title TBA

Plenary Lecture:

Yu-Shan Lin, PhD

Professor and Department Chair, Chemistry @ Tufts University

Structure Prediction of Cyclic Peptides Via Molecular Dynamics and Machine Learning 

Rebecca Swett, PhD

Director of Computational Chemistry Innovation @ X-Chem

Computational chemistry - Title TBA

Taylor Quinn, PhD

Associate Principal Scientist @ AstraZeneca

AI in drug discovery (developing the Cbl-b inhibitors for cancer immunotherapy)- Title TBA 

Ludivine Moine, MSc

Senior Scientist II @ Blueprint Medicines

Design and Synthesis of BLU-654, a Potent and Selective Mutant KIT V654A Inhibitor for the Treatment of imatinib-resistant GIST

Murray Wan, PhD

Principal Scientist @ Mariana Oncology a Novartis Company

ETN029:Discovery of a DLL3-targeted Radioligand Therapy for the Treatment of SCLC and Beyond

Anne Marinier, PhD

Director of the Discovery Unit, IRIC; Prof. Department of Pharmacology & Physiology, University de Montreal

Topic: UM171, a molecular glue (leukemia/blood cancer treatment) - talk title TBA

Elsie Yu, PhD

Associate Principal Scientist @ Merck

IL4i1 Inhibitors from Target Validation Through to First-In-Human Studies in Cancer Patients

MOMA Therapeutics

Speaker name TBA

Topic: Inhibitor of WRN Helicase